Patent court to review Alexion’s Soliris patents on Amgen challenge – Reuters

  1. Patent court to review Alexion’s Soliris patents on Amgen challenge  Reuters
  2. Alexion shares slide on Amgen patent challenge to top-seller  BioPharma Dive
  3. Patent Challenge to Alexion Proceeds, But No Amgen Biosimilar Yet  Xconomy
  4. Options Pop on Alexion Stock Amid Patent Questions  Yahoo Finance
  5. View full coverage on Google News